Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$67.08 USD
+0.05 (0.07%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $67.50 +0.42 (0.63%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth F Momentum C VGM
Brokerage Reports
0 items in cart
Gilead Sciences, Inc. [GILD]
Reports for Purchase
Showing records 41 - 60 ( 521 total )
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for GILD 4123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for GILD 32123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for GILD 31123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for GILD 3123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for GILD 22123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for GILD 21123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for GILD 2123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for GILD 12123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for GILD 11123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for GILD 1123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for GILD 122122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended December 9.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for GILD 121122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for GILD 12122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for GILD 112122
Provider: Stock Traders Daily
Analyst: Research Department